Additionally, ESCC miRNA, by either targeting nuclear receptor subfamily 2 through indirect positive regulation of OCT4 or inhibiting the TGF-β signaling pathway, synergistically enhance MET and reprogramming of MV(O)MTS375(SK) (M).61 This evidence concerns the gene POU5F1 and esophageal squamous cell carcinoma.